LEVOBUNOLOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levobunolol Hydrochloride, and what generic alternatives are available?
Levobunolol Hydrochloride is a drug marketed by Alcon Labs Inc, Apotex Inc, Bausch And Lomb, and Sandoz. and is included in six NDAs.
The generic ingredient in LEVOBUNOLOL HYDROCHLORIDE is levobunolol hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levobunolol Hydrochloride
A generic version of LEVOBUNOLOL HYDROCHLORIDE was approved as levobunolol hydrochloride by BAUSCH AND LOMB on March 4th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVOBUNOLOL HYDROCHLORIDE?
- What are the global sales for LEVOBUNOLOL HYDROCHLORIDE?
- What is Average Wholesale Price for LEVOBUNOLOL HYDROCHLORIDE?
Summary for LEVOBUNOLOL HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Patent Applications: | 563 |
DailyMed Link: | LEVOBUNOLOL HYDROCHLORIDE at DailyMed |
![LEVOBUNOLOL HYDROCHLORIDE drug patent expirations Drug patent expirations by year for LEVOBUNOLOL HYDROCHLORIDE](/p/graph/s/t/LEVOBUNOLOL_HYDROCHLORIDE-patent-expirations.png)
Pharmacology for LEVOBUNOLOL HYDROCHLORIDE
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |